Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study.
Clinical trial NCT06239389 · COMPLETED
Trial details
- NCT number
- NCT06239389
- Sponsor
- National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2021-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.